Zymosan attenuates melanoma growth progression, increases splenocyte proliferation and induces TLR-2/4 and TNF-α expression in mice

Role of pathogen-associated molecular patterns (PAMPS) in immune responses to fungal infections

(2017) Mehdi Taghavi et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Extraction of β-glucan from Saccharomyces cerevisiae: Comparison of different extraction methods and in vivo assessment of immunomodulatory effect in mice

(2016) Noppawat PENGKUMSRI et al.   Food Science and Technology

Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma

(2016) Mikko Siurala et al.   MOLECULAR THERAPY

Triggering Dectin-1-Pathway Alone Is Not Sufficient to Induce Cytokine Production by Murine Macrophages

(2016) Sarah Walachowski et al.   PLoS One

Extraction of β-glucan from Saccharomyces cerevisiae: Comparison of different extraction methods and in vivo assessment of immunomodulatory effect in mice

(2016) Noppawat PENGKUMSRI et al.   Food Science and Technology

Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study

(2015) Riccardo Danielli et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

A novel apoptosis-inducing mechanism of 5-aza-2′-deoxycitidine in melanoma cells: Demethylation of TNF-α and activation of FOXO1

(2015) Shunsuke Noguchi et al.   CANCER LETTERS

Molecular pathway activation features linked with transition from normal skin to primary and metastatic melanomas in human

(2015) Denis Shepelin et al.   Oncotarget

Resolution of acute inflammation bridges the gap between innate and adaptive immunity

(2014) J. Newson et al.   BLOOD

Interaction of Pattern Recognition Receptors with Mycobacterium Tuberculosis

(2014) Esmaeil Mortaz et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Review of Natural Compounds for Potential Skin Cancer Treatment

(2014) Tawona Chinembiri et al.   MOLECULES

NMR study of short β(1-3)-glucans provides insights into the structure and interaction with Dectin-1

(2013) Shinya Hanashima et al.   GLYCOCONJUGATE JOURNAL

Innate and adaptive immune cells in the tumor microenvironment

(2013) Thomas F Gajewski et al.   NATURE IMMUNOLOGY

Immunomodulatory Activity of a Novel, Synthetic Beta-glucan (β-glu6) in Murine Macrophages and Human Peripheral Blood Mononuclear Cells

(2013) Xiaofei Li et al.   PLoS One

T cell activation status determines the cytokine pattern induced by zymosan and bacterial DNA both in thymocytes and splenocytes

(2012) C. Zimmermann et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Comparison of the potency of a variety of β-glucans to induce cytokine production in human whole blood

(2012) Ilka Noss et al.   Innate Immunity

Differential Constitutive and Cytokine-Modulated Expression of Human Toll-like Receptors in Primary Neutrophils, Monocytes, and Macrophages

(2012) D. Shane O'Mahony et al.   International Journal of Medical Sciences

Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived  -glucans

(2011) C. Qi et al.   BLOOD

Effect of Zymosan on Antioxidant and Immune Function of S180 Tumor-Bearing Mice

(2011) Xiao-li Liu et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

Bmi-1 Is a Crucial Regulator of Prostate Stem Cell Self-Renewal and Malignant Transformation

(2010) Rita U. Lukacs et al.   Cell Stem Cell

Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells

(2010) H. Lu et al.   CLINICAL CANCER RESEARCH

A new understanding in the epidemiology of melanoma

(2010) Esther Erdei et al.   Expert Review of Anticancer Therapy

Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms

(2009) Xiaoyu Hu et al.   IMMUNOLOGICAL REVIEWS

A New Strategy for the Identification of Novel Molecules with Targeted Proresolution of Inflammation Properties

(2009) R. A. Navarro-Xavier et al.   JOURNAL OF IMMUNOLOGY

Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury

(2009) Justin D. Ellett et al.   LIVER TRANSPLANTATION

Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors

(2008) Y. Goto et al.   MOLECULAR CANCER THERAPEUTICS